Imaging

Coronary CT calcium score

CAC · Agatston score · Coronary artery calcium

A direct visualisation of coronary atherosclerosis — refines cardiovascular risk far more sharply than any single blood marker.

Strong relevance3 cited sourcesNo fasting€150–500 private; rarely covered by public systems unless symptomatic.movementnutritionstress

What it measures

Non-contrast CT scan quantifying calcified plaque in the coronary arteries. The Agatston score sums calcium-area × density across the four major coronary territories. A score of zero is a powerful negative predictor; rising scores predict events in a dose-dependent way.

Reference context

4 guideline sources

Age- and sex-adjusted percentiles (MESA calculator) are more informative than the absolute score for adults under 60, because absolute scores rise with age. A score of 50 at age 45 is more concerning than a score of 200 at age 75.

CAC 0
1–99
100–299
≥300
Lower riskHigher risk

Population context — consult guideline targets below

Mechanism

Why moving this marker matters

Coronary calcification is a marker of established atherosclerotic plaque burden. While vulnerable plaque is non-calcified, total plaque burden (including the calcified component visible on CT) is strongly correlated with event risk. Mendelian-randomisation and prospective cohort data both support causal inference.

Guideline targets

What major guidelines recommend

ACC/AHA — CAC 0

Strong

Very low 10-year ASCVD risk; statin generally deferrable in absence of other risk factors.

ACC/AHA — CAC 1–99

Strong

Mildly elevated burden; lifestyle plus consideration of pharmacotherapy depending on absolute risk.

ACC/AHA — CAC 100–299

Strong

Moderate burden; statin therapy generally indicated.

ACC/AHA — CAC ≥300 or ≥75th percentile for age/sex

Strong

High burden; aggressive risk-factor modification.

How to measure

The test, where to get it, when to repeat

Method

Non-contrast CT scan, ~10 minutes, single breath-hold. Radiation dose ~1 mSv (similar to mammography).

Where

Hospital cardiology imaging or specialist private clinic; increasingly available through preventive-health providers (Prenuvo, Ezra, Neko Health, longevity clinics).

Typical cost

€150–500 private; rarely covered by public systems unless symptomatic.

Fasting

Not required

When to test

  • ACC/AHA 2018

    40–75

    Class IIa for adults aged 40–75 at borderline-to-intermediate 10-year ASCVD risk (5–20%); particularly useful when decision-making about statin therapy is uncertain.

  • ESC 2021

    40+

    May be considered to refine risk estimation in asymptomatic adults at moderate risk.

  • MESA cohort guidance

    Repeat scoring after 5–7 years is informative for risk re-classification.

Where to scan

Providers offering this imaging study

These providers offer the scan directly to consumers. You book and pay with them; the imaging report lives on their platform. Healicus is not in the clinical chain.

Healicus is not the provider. Your contract for the service is with whoever you choose. Links labelled Sponsored are paid affiliate relationships; unlabelled links are editorial reference only. See our disclosure for the full policy.

Context

Reading the numbers

Age- and sex-adjusted percentiles (MESA calculator) are more informative than the absolute score for adults under 60, because absolute scores rise with age. A score of 50 at age 45 is more concerning than a score of 200 at age 75.

Caveats

CAC measures only calcified plaque. A zero score does not exclude soft (non-calcified) plaque, which is more common in younger adults and people with diabetes. A high score in older adults reflects historical, not necessarily active, disease.

See also

Related markers

Take to your physician

Worth discussing

  • Whether your absolute risk estimate, calcium score, and percentile justify statin therapy or further imaging.
  • If your score is zero, when (if ever) to repeat it.
  • How to interpret rising scores between scans (progression is common; absolute rate matters more than presence of any rise).

Sources

Cited literature

Edited by Carl Pöhl, MD · Healicus editorial

Educational reference. Population-level information for the longevity-curious reader. Healicus does not compute scores, interpret your specific values, or produce personalised recommendations from your clinical data. Discuss your own results and any decisions with your physician.

Keep reading